SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) – Neurocrine Biosciences, Inc. Transaction History
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) portfolio value:
$16.65M
portfolio value
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.77% | 4.23K shares | 1.78M | $106.21 | 156.78K |
| Q2 2022 | share | Decrease | -1.74% | -2.70K shares | 316K | $97.48 | 152.55K |
| Q1 2022 | share | Increase | +1.06% | 1.63K shares | 1.55M | $93.75 | 155.25K |
| Q4 2021 | share | Decrease | -0.07% | -114 shares | -1.74M | $84.63 | 153.62K |
| Q3 2021 | share | Decrease | -0.25% | -380 shares | -253K | $95.91 | 153.73K |
| Q2 2021 | share | Increase | +12.06% | 16.58K shares | 1.62M | $97.32 | 154.11K |
| Q1 2021 | share | Increase | +146.41% | 81.71K shares | 8.02M | $97.25 | 137.52K |
| Q4 2020 | share | Decrease | -0.63% | -356 shares | -51K | $95.85 | 55.81K |
| Q3 2020 | share | Increase | +23.72% | 10.77K shares | -138K | $96.16 | 56.17K |
| Q2 2020 | share | Increase | +15.23% | 6K shares | 2.12M | $122 | 45.4K |
| Q1 2020 | share | Decrease | -26.08% | -13.9K shares | -2.31M | $86.55 | 39.4K |
| Q4 2019 | share | Increase | +12.45% | 5.9K shares | 1.45M | $107.49 | 53.3K |
| Q3 2019 | share | Decrease | -14.44% | -8K shares | -406K | $90.11 | 47.4K |
| Q2 2019 | share | Increase | 0.00% | 55.4K shares | 4.67M | $84.43 | 55.4K |